MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$130,778K
Foreign currency
translation adjustment
$2K
Unrealized gain (loss) on
marketable securities
-$167K
Net loss
-$130,613K
Other income, net
$24,765K
Provision for income taxes
$614K
Net loss before
income taxes
-$129,999K
Total other income,
net
$24,765K
Grant
$865K
Loss from operations
-$154,764K
Total revenue
$864K
Total operating
expenses
$155,628K
Collaboration expense, net
$53,703K
General and
administrative
$18,399K
Research and development
$83,526K
Back
Back
Income Statement
source: myfinsight.com
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP)